Form 4: Standex International Director Sells Shares

Thomas E. Chorman, a Director at Standex International Corp., reported a sale of 50 shares of common stock on July 1, 2026, executed under a pre-existing 10b5-1 trading plan.

Summary

• Director Thomas E. Chorman sold 50 shares of Standex International Corp. common stock on July 1, 2026.
• The transaction was conducted under a Rule 10b5-1 trading plan established on November 6, 2025.
• The sale price was $355.51 per share.
• Following this transaction, Chorman beneficially owns 12,416 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing as the sale was conducted under a pre-arranged 10b5-1 plan, indicating it was likely planned in advance and not necessarily a reflection of negative sentiment towards the company's future prospects.

Negatives

• Director Thomas E. Chorman sold 50 shares of common stock.

Future Outlook

No specific future outlook or guidance is provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings typically report transactions by company insiders, such as directors and officers. Sales under a 10b5-1 plan are pre-arranged and can be a routine part of an executive's financial planning, but are still closely watched by the market.

Stakeholder Impact

• Shareholders may view insider sales with caution, although the pre-arranged nature of this transaction under a 10b5-1 plan mitigates immediate concern.

Key Dates

Keywords

Standex International Corp, SXI, Form 4, Insider Trading, 10b5-1 plan, Director Sale, Common Stock